| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8221195 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
Based on this small series of sGBM patients treated with CRTx (concomitantly or sequentially) the frequency of PP appears to be very low in sGBM, even in those patients with methylated MGMT promoter or IDH mutations. Our results highlight the differences between primary glioblastomas and sGBM in particular as they relate to PP.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tareq A. MD, Kay MD, Tim MD, Kathrin D. MD, Rüdiger MD, Jana MD, Arnab MD, Dietmar MD, Gabriele MD,